Repligen Reports Second Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

Go back to Repligen Reports Second Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

Repligen (RGEN) Tops Q2 EPS by 6c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

August 1, 2019 7:52 AM EDT

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.31, $0.06 better than the analyst estimate of $0.25. Revenue for the quarter came in at $70.7 million versus the consensus estimate of $63.89 million.

Reports record quarterly revenue of $70.7 million, representing 48% year-over-year growth and 46% organic growthRaises revenue guidance to $264-$268 million for full year 2019, representing 29%-31% organic growthCompletes acquisition of process analytics innovator C TechnologiesCloses follow-on equity and convertible debt offerings for net proceeds of $599 million

Second Quarter 2019 Highlights

Revenue increased by 48% year-over-year, and 46% organically, to a record $70.7 millionGAAP income from operations increased 670 bps to 15.6% of... More